» Articles » PMID: 36121498

Simulations of Topiramate Dosage Recommendations for Poor Compliance Events

Overview
Specialty Pharmacology
Date 2022 Sep 19
PMID 36121498
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the influences of one or two consecutive missed topiramate (TPM) doses on TPM pharmacokinetics and to suggest the proper TPM replacement dosing schemes using Monte Carlo simulations.

Methods: Monte Carlo simulations were performed for various replacement dosing schemes using the parameters from the published population pharmacokinetic models. The lowest percentage of deviation of simulated concentrations outside the reference range of 5-20 mg/L from the compliance scenario for each replacement dosing scheme was used as a criterion for choosing the proper replacement dosing scheme.

Results: For the one missed dose, the replacement with an immediate regular dose and a partial dose resulted in the lowest and highest percentages of concentration below 5 mg/L, respectively. While the opposite results were observed for the upper bound of the reference range (20 mg/L). For the two consecutive missed doses, the replacement with one and a half-missed doses resulted in a lower percentage of deviation of concentrations below 5 mg/L from the compliance scenario than the replacement with one regular dose.

Conclusions: For the one missed dose, taking an immediate regular dose might be suitable for patients who require higher TPM levels, while for patients who require lower TPM levels, an immediate partial dose could be used. For the two consecutive missed doses, an immediate one and a half regular dose might be suitable. However, these results were merely based on simulations; thus, they should be used alongside the clinician's justification based on seizure control.

Citing Articles

Population pharmacokinetics of topiramate in Chinese children with epilepsy.

Wei S, Li X, Zhang Q, Wu H, Wu Y, Zhao Z Eur J Clin Pharmacol. 2023; 79(10):1401-1415.

PMID: 37597080 DOI: 10.1007/s00228-023-03549-6.

References
1.
Patsalos P, Berry D, Bourgeois B, Cloyd J, Glauser T, Johannessen S . Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008; 49(7):1239-76. DOI: 10.1111/j.1528-1167.2008.01561.x. View